1 Min Read
Dec 22 (Reuters) - Airxpanders Inc
* Airxpanders has received u.s. Food and drug administration (FDA) de novo clearance for aeroform Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.